Vasoactive intestinal peptide (VIP) enhances the cell motility of androgen receptor-transfected DU-145 prostate cancer cells (DU-145/AR)
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Keyword(s):
Keyword(s):